Abstract
The pathophysiology of TBI can be considered as a dual insult composed of primary and secondary injuries. Growing experimental and clinical evidence suggests that disturbances of cerebral energy metabolism are a key factor in the pathogenesis of secondary cerebral damages. In addition, hormonal dysfunction after TBI, such as adrenal insufficiency, vasopressin, growth hormone, or thyrothropin deficiency, can be associated with poor prognosis. A better understanding of energy metabolism and hormonaldisturbances after TBIis necessary to improve the care management at the early phase of TBI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zaloshnja E, Miller T, Langlois JA, Selassie AW (2008) Prevalence of long-term disability from traumatic brain injury in the civilian population of the United States, 2005. J Head Trauma Rehabil 23(6):394–400
Jeremitsky E, Omert L, Dunham CM, Protetch J, Rodriguez A (2003) Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion. J Trauma 54(2):312–319
Hutchinson PJ, Jalloh I, Helmy A et al (2015) Consensus statement from the 2014 International Microdialysis Forum. Intensive Care Med 41(9):1517–1528
Hillered L, Vespa PM, Hovda DA (2005) Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 22(1):3–41
Timofeev I, Carpenter KL, Nortje J et al (2011) Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain 134(Pt 2):484–494
Barros LF, Deitmer JW (2010) Glucose and lactate supply to the synapse. Brain Res Rev 63(1–2):149–159
Pellerin L, Magistretti PJ (2012) Sweet sixteen for ANLS. J Cereb Blood Flow Metab 32(7):1152–1166
Magistretti PJ (2009) Role of glutamate in neuron-glia metabolic coupling. Am J Clin Nutr 90(3):875S–880S
Sala N, Suys T, Zerlauth JB et al (2013) Cerebral extracellular lactate increase is predominantly nonischemic in patients with severe traumatic brain injury. J Cereb Blood Flow Metab 33(11):1815–1822
Magnoni S, Tedesco C, Carbonara M et al (2012) Relationship between systemic glucose and cerebral glucose is preserved in patients with severe traumatic brain injury, but glucose delivery to the brain may become limited when oxidative metabolism is impaired: implications for glycemic control. Crit Care Med 40(6):1785–1791
Finfer S, Chittock D, Li Y et al (2015) Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study. Intensive Care Med 41(6):1037–1047
Kalfon P, Le Manach Y, Ichai C et al (2015) Severe and multiple hypoglycemic episodes are associated with increased risk of death in ICU patients. Crit Care 19:153
Vespa P, McArthur DL, Stein N et al (2012) Tight glycemic control increases metabolic distress in traumatic brain injury: a randomized controlled within-subjects trial. Crit Care Med 40(6):1923–1929
Meierhans R, Bechir M, Ludwig S et al (2010) Brain metabolism is significantly impaired at blood glucose below 6 mM and brain glucose below 1 mM in patients with severe traumatic brain injury. Crit Care 14(1):R 13
Valente-Silva P, Lemos C, Kofalvi A, Cunha RA, Jones JG (2015) Ketone bodies effectively compete with glucose for neuronal acetyl-CoA generation in rat hippocampal slices. NMR Biomed 28(9):1111–1116
Schurr A, Payne RS, Miller JJ, Rigor BM (1997) Brain lactate, not glucose, fuels the recovery of synaptic function from hypoxia upon reoxygenation: an in vitro study. Brain Res 744(1):105–111
Cater HL, Chandratheva A, Benham CD, Morrison B, Sundstrom LE (2003) Lactate and glucose as energy substrates during, and after, oxygen deprivation in rat hippocampal acute and cultured slices. J Neurochem 87(6):1381–1390
Gallagher CN, Carpenter KL, Grice P et al (2009) The human brain utilizes lactate via the tricarboxylic acid cycle: a 13C-labelled microdialysis and high-resolution nuclear magnetic resonance study. Brain 132(Pt 10):2839–2849
Boumezbeur F, Petersen KF, Cline GW et al (2010) The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy. J Neurosci 30(42):13983–13991
Sotelo-Hitschfeld T, Fernandez-Moncada I, Barros LF (2012) Acute feedback control of astrocytic glycolysis by lactate. Glia 60(4):674–680
Bouzat P, Sala N, Suys T et al (2014) Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain. Intensive Care Med 40(3):412–421
Berthet C, Castillo X, Magistretti PJ, Hirt L (2012) New evidence of neuroprotection by lactate after transient focal cerebral ischaemia: extended benefit after intracerebroventricular injection and efficacy of intravenous administration. Cerebrovasc Dis 34(5–6):329–335
Ichai C, Armando G, Orban JC et al (2009) Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med 35(3):471–479
Ichai C, Payen JF, Orban JC et al (2013) Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe traumatic brain injured patients: a randomized controlled trial. Intensive Care Med 39(8):1413–1422
Kelly DF, Gonzalo IT, Cohan P et al (2000) Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg 93(5):743–752
Schneider HJ, Schneider M, Saller B et al (2006) Prevalence of anterior pituitary insufficiency 3 and 12 months after traumatic brain injury. Eur J Endocrinol 154(2):259–265
Agha A, Sherlock M, Phillips J, Tormey W, Thompson CJ (2005) The natural history of post-traumatic neurohypophysial dysfunction. Eur J Endocrinol 152(3):371–377
Cohan P, Wang C, McArthur DL et al (2005) Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med 33(10):2358–2366
Kokshoorn NE, Smit JW, Nieuwlaat WA et al (2011) Low prevalence of hypopituitarism after traumatic brain injury: a multicenter study. Eur J Endocrinol 165(2):225–231
Powner DJ, Boccalandro C, Alp MS, Vollmer DG (2006) Endocrine failure after traumatic brain injury in adults. Neurocrit Care 5(1):61–70
Prigent H, Maxime V, Annane D (2004) Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care 8(4):243–252
Koiv L, Merisalu E, Zilmer K, Tomberg T, Kaasik AE (1997) Changes of sympatho-adrenal and hypothalamo-pituitary-adrenocortical system in patients with head injury. Acta Neurol Scand 96(1):52–58
Bernard F, Outtrim J, Menon DK, Matta BF (2006) Incidence of adrenal insufficiency after severe traumatic brain injury varies according to definition used: clinical implications. Br J Anaesth 96(1):72–76
Cooper MS, Thickett DR, Stewart PM (2013) Reduced cortisol metabolism during critical illness. N Engl J Med 369(5):480
Agha A, Phillips J, O’Kelly P, Tormey W, Thompson CJ (2005) The natural history of post-traumatic hypopituitarism: implications for assessment and treatment. Am J Med 118(12):1416
Marik PE (2009) Critical illness-related corticosteroid insufficiency. Chest 135(1):181–193
Bondanelli M, De Marinis L, Ambrosio MR et al (2004) Occurrence of pituitary dysfunction following traumatic brain injury. J Neurotrauma 21(6):685–696
Llompart-Pou JA, Perez-Barcena J, Raurich JM et al (2007) Effect of barbiturate coma on adrenal response in patients with traumatic brain injury. J Endocrinol Invest 30(5):393–398
Vinclair M, Broux C, Faure P et al (2008) Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med 34(4):714–719
Barton RN, Stoner HB, Watson SM (1987) Relationships among plasma cortisol, adrenocorticotrophin, and severity of injury in recently injured patients. J Trauma 27(4):384–392
Alderson P, Roberts I (2000) Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev (2):CD000196
Roberts I, Yates D, Sandercock P et al (2004) Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 364(9442):1321–1328
Treschan TA, Peters J (2006) The vasopressin system: physiology and clinical strategies. Anesthesiology 105(3):599–612
Boughey JC, Yost MJ, Bynoe RP (2004) Diabetes insipidus in the head-injured patient. Am Surg 70(6):500–503
Schrier RW, Gross P, Gheorghiade M et al (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355(20):2099–2112
Spasovski G, Vanholder R, Allolio B et al (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 40(3):320–331
Bushnik T, Englander J, Katznelson L (2007) Fatigue after TBI: association with neuroendocrine abnormalities. Brain Inj 21(6):559–566
Devesa J, Reimunde P, Devesa P, Barbera M, Arce V (2013) Growth hormone (GH) and brain trauma. Horm Behav 63(2):331–344
Chourdakis M, Kraus MM, Tzellos T et al (2012) Effect of early compared with delayed enteral nutrition on endocrine function in patients with traumatic brain injury: an open-labeled randomized trial. JPEN J Parenter Enteral Nutr 36(1):108–116
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Quintard, H., Ichai, C., Payen, JF. (2016). The Stress Response after Traumatic Brain Injury: Metabolic and Hormonal Aspects. In: Preiser, JC. (eds) The Stress Response of Critical Illness: Metabolic and Hormonal Aspects. Springer, Cham. https://doi.org/10.1007/978-3-319-27687-8_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-27687-8_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27685-4
Online ISBN: 978-3-319-27687-8
eBook Packages: MedicineMedicine (R0)